These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 35526977)

  • 1. Intrathecal Pumps.
    Ericson T; Singla P; Kohan L
    Phys Med Rehabil Clin N Am; 2022 May; 33(2):409-424. PubMed ID: 35526977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal pain pumps in pain relief.
    Mahawar B; Kannan A; Mahawar V; Srinivasan S
    Clin Radiol; 2023 Apr; 78(4):240-244. PubMed ID: 36841671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longevity and cost of implantable intrathecal drug delivery systems for chronic pain management: a retrospective analysis of 365 patients.
    Bolash R; Udeh B; Saweris Y; Guirguis M; Dalton JE; Makarova N; Mekhail N
    Neuromodulation; 2015 Feb; 18(2):150-5; discussion 155-6. PubMed ID: 25250852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Intrathecal Pumps in Nonmalignant Pain.
    Ginalis EE; Ali S; Mammis A
    Neurosurg Clin N Am; 2022 Jul; 33(3):305-309. PubMed ID: 35718400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal drug delivery for chronic pain management-scope, limitations and future.
    Czernicki M; Sinovich G; Mihaylov I; Nejad B; Kunnumpurath S; Kodumudi G; Vadivelu N
    J Clin Monit Comput; 2015 Apr; 29(2):241-9. PubMed ID: 25173564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intrathecal drug delivery for chronic pain management].
    Perruchoud C; Cachemaille M
    Rev Med Suisse; 2022 Jun; 18(787):1254-1258. PubMed ID: 35735149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic review of intrathecal infusion systems for long-term management of chronic non-cancer pain.
    Patel VB; Manchikanti L; Singh V; Schultz DM; Hayek SM; Smith HS
    Pain Physician; 2009; 12(2):345-60. PubMed ID: 19305484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal therapy for cancer and non-cancer pain.
    Hayek SM; Deer TR; Pope JE; Panchal SJ; Patel VB
    Pain Physician; 2011; 14(3):219-48. PubMed ID: 21587327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal drug delivery for pain: a clinical guide and future directions.
    Pope JE; Deer TR
    Pain Manag; 2015; 5(3):175-83. PubMed ID: 25971641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal pain pumps: indications, patient selection, techniques, and outcomes.
    Bolash R; Mekhail N
    Neurosurg Clin N Am; 2014 Oct; 25(4):735-42. PubMed ID: 25240660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Outcomes Using Intrathecal Drug Delivery Systems in Complex Regional Pain Syndrome.
    Herring EZ; Frizon LA; Hogue O; Mejia JU; Rosenquist R; Bolash RB; Machado AG; Nagel SJ
    Pain Med; 2019 Mar; 20(3):515-520. PubMed ID: 29889241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near Death Experience from Placement of an Intrathecal Catheter.
    Padalia D; Jassal N; Patel S
    Pain Physician; 2016 May; 19(4):E621-3. PubMed ID: 27228528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal delivery of analgesics.
    De Andres J; Asensio-Samper JM; Fabregat-Cid G
    Methods Mol Biol; 2014; 1141():249-78. PubMed ID: 24567144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study.
    Mohammed SI; Eldabe S; Simpson KH; Brookes M; Madzinga G; Gulve A; Baranidharan G; Radford H; Crowther T; Buchser E; Perruchoud C; Batterham AM
    Neuromodulation; 2013; 16(6):576-81; discussion 582. PubMed ID: 23205907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal analgesia: time to consider it for your patient?
    Shaparin N; Sim A; Pappagallo M; Gritsenko K; Carullo V; Tsukanov J; Kosharskyy B
    J Fam Pract; 2015 Mar; 64(3):166-72. PubMed ID: 25789343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Audit of intrathecal drug delivery for patients with difficult-to-control cancer pain shows a sustained reduction in pain severity scores over a 6-month period.
    Mitchell A; McGhie J; Owen M; McGinn G
    Palliat Med; 2015 Jun; 29(6):554-63. PubMed ID: 25690600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a Targeted Drug Delivery on-Demand Bolus Option for Chronic Pain.
    Bolash RB; Niazi T; Kumari M; Azer G; Mekhail N
    Pain Pract; 2018 Mar; 18(3):305-313. PubMed ID: 28520273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Massive clonidine overdose during refill of an implanted drug delivery device for intrathecal analgesia: a review of inadvertent soft-tissue injection during implantable drug delivery device refills and its management.
    Johnson ML; Visser EJ; Goucke CR
    Pain Med; 2011 Jul; 12(7):1032-40. PubMed ID: 21672143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.